CELUW logo

Celularity Inc. (CELUW)

Profile

Full Name

Celularity Inc.

Ticker

NASDAQ: CELUW

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 19, 2021

Indexes

Not included

Website

https://www.celularity.com

Employees

123

Key Details

Price

$0.05(-0.20%)

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$54.22M(+138.11% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.05
    CELUW price is $0.05

    30-Day Relative Volume

    2.77
    CELUW 30-day relative volume is 2.77

    Price Performance

    Price Most recent change

    -0.2%
    CELUW price was down -0.2% on Sep 16, 2025

    Price YTD change

    +177.22%
    CELUW price is up +177.22% since January 1st

    Price 1-year change

    +172.68%
    CELUW price is up +172.68% year-on-year

    Price 3-year change

    -85.32%
    CELUW price is down -85.32% over the past 3 years

    Price Range

    Price All-time high

    $4583.60
    CELUW price is currently -100.00% below its historical high of $4583.60

    Price 3-year low

    $0.00
    CELUW price is currently +1147.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    CELUW market capitalization value is unknown

    Market cap 3-year change

    -
    CELUW market capitalization 3-year change is unknown

    Market cap All-time high

    -
    CELUW market capitalization all-time high is unknown

    Market cap sector rank

    -
    CELUW market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    CELUW shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    CELUW shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.01
    CELUW beta is 0.01

    200-day SMA

    $0.04
    CELUW price is currently +18.25% above its 200-day simple moving average

    50-day SMA

    $0.05
    CELUW price is currently +2.89% above its 50-day simple moving average

    RSI

    51.02
    CELUW 14-day relative strength index is 51.02

    Volume

    2.77
    CELUW 30-day relative volume is 2.77

    ATR

    $0.07
    CELUW average true range is $0.07

    10-day Historical Volatility

    276.96%
    CELUW 10-day historical volatility is 276.96%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $54.22M
    CELUW annual revenue is $54.22 million

    Revenue Analysts estimate

    -
    CELUW annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +138.11%
    CELUW annual revenue is up +138.11% year-on-year

    Revenue Sector rank

    62.15%
    CELUW annual revenue is higher than 62.15% of companies in Healthcare sector

    EPS

    EPS

    -
    CELUW annual earnings per share value is unknown

    EPS Analysts estimate

    -
    CELUW annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -
    CELUW annual earnings per share 1-year change is unknown

    EPS Sector rank

    -
    CELUW annual earnings per share is unknown

    Profit

    Gross profit

    $39.23M
    CELUW annual gross profit is $39.23 million

    Gross margin

    72.36%
    CELUW annual gross profit margin is 72.36%

    Operating profit

    -$38.55M
    CELUW annual operating income is -$38.55 million

    Operating margin

    -71.10%
    CELUW annual operating profit margin is -71.10%

    Net income

    -$57.89M
    CELUW annual net profit is -$57.89 million

    Net margin

    -
    CELUW annual net profit margin value is unknown

    Expenses

    Total expenses

    $92.77M
    CELUW annual total expenses is $92.77 million

    Operating expenses

    $77.78M
    CELUW annual total operating expenses is $77.78 million

    Cost of goods sold

    $14.99M
    CELUW annual cost of goods sold is $14.99 million

    Selling, general & administrative expenses

    $58.64M
    CELUW annual SGA is $58.64 million

    Depreciation and amortization

    $7.92M
    CELUW annual depreciation & amortization is $7.92 million

    Interest expense

    $6.26M
    CELUW annual interest expense is $6.26 million

    Income tax

    $0.00
    CELUW annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$51.63M
    CELUW annual earnings before interest & taxes is -$51.63 million

    EBITDA

    -$40.39M
    CELUW annual EBITDA is -$40.39 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $132.68M
    CELUW annual total assets is $132.68 million

    Non current assets

    $112.12M
    CELUW annual long term assets is $112.12 million

    Current assets

    $20.56M
    CELUW annual total current assets is $20.56 million

    Cash and cash equivalents

    $738.00K
    CELUW annual cash & cash equivalents is $738.00 thousand

    Accounts receivable

    $13.56M
    CELUW annual accounts receivable is $13.56 million

    Inventory

    $5.41M
    CELUW annual inventory is $5.41 million

    Liabilities

    Total liabilities

    $123.84M
    CELUW annual total liabilities is $123.84 million

    Long term liabilities

    $70.17M
    CELUW annual total long term liabilities is $70.17 million

    Current liabilities

    $53.68M
    CELUW annual total current liabilities is $53.68 million

    Accounts payable

    $23.30M
    CELUW annual accounts payable is $23.30 million

    Debt

    Total debt

    $68.84M
    CELUW annual total debt is $68.84 million

    Total debt 1-year change

    +5.23%
    CELUW annual total debt is up +5.23% year-on-year

    Long term debt

    $62.48M
    CELUW annual long term debt is $62.48 million

    Short term debt

    $6.36M
    CELUW annual short term debt is $6.36 million

    Equity & Capital

    Shareholders equity

    $8.84M
    CELUW annual stockholders equity is $8.84 million

    Book value

    -$7.76M
    CELUW annual book value is -$7.76 million

    Retained earnings

    -$899.68M
    CELUW annual retained earnings is -$899.68 million

    Working capital

    -$33.12M
    CELUW annual working capital is -$33.12 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$6.40M
    CELUW annual cash flow from operations is -$6.40 million

    Cash from operations 1-year change

    +83.45%
    CELUW annual cash flow from operations is up +83.45% year-on-year

    Cash from investing

    $514.00K
    CELUW annual cash flow from investing activities is $514.00 thousand

    Cash from investing 1-year change

    +112.7%
    CELUW annual cash flow from investing activities is up +112.7% year-on-year

    Cash from financing

    $6.70M
    CELUW annual cash flow from financing activities is $6.70 million

    Cash from financing 1-year change

    -72.19%
    CELUW annual cash flow from financing activities is down -72.19% year-on-year

    CAPEX

    CAPEX

    $161.00K
    CELUW annual capital expenditures is $161.00 thousand

    CAPEX 1-year change

    -96.02%
    CELUW annual capital expenditures is down -96.02% year-on-year

    Free Cash Flow

    Free cash flow

    -$6.56M
    CELUW annual free cash flow is -$6.56 million

    Free cash flow 1-year change

    +84.64%
    CELUW annual free cash flow is up +84.64% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    72.36%
    CELUW annual gross profit margin is 72.36%

    Operating margin

    -71.10%
    CELUW annual operating profit margin is -71.10%

    Net margin

    -
    CELUW annual net profit margin value is unknown

    ROA & ROE

    ROA

    -43.63%
    CELUW annual return on assets is -43.63%

    ROE

    -655.11%
    CELUW annual return on equity is -655.11%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CELUW price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CELUW price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    CELUW price to book ratio value is unknown

    PB ratio Sector rank

    -
    CELUW price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    CELUW price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CELUW price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    CELUW enterprise value value is unknown

    Enterprise value Sector rank

    -
    CELUW enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    CELUW EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    CELUW EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.38
    CELUW annual current ratio is 0.38

    Quick ratio

    0.28
    CELUW annual quick ratio is 0.28

    Leverage

    Debt to equity

    7.79
    CELUW annual debt to equity ratio is 7.79

    Interest coverage ratio

    -8.24
    CELUW annual interest coverage ratio is -8.24

    Risk & Stability

    Piotroski F-Score

    -
    CELUW piotroski f-score value is unknown

    Altman Z-Score

    -
    CELUW altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jan 30, 23 Morgan Stanley
    Underweight
    Jan 30, 23 HC Wainwright & Co.
    Buy
    Dec 22, 22 Oppenheimer
    Perform
    Sep 12, 22 Morgan Stanley
    Equal-Weight
    Aug 25, 22 Alliance Global Partners
    Buy
    Aug 23, 22 Truist Securities
    Hold
    Jun 22, 22 HC Wainwright & Co.
    Buy
    Apr 6, 22 Truist Securities
    Hold
    Jan 28, 22 Oppenheimer
    Outperform
    Nov 24, 21 Morgan Stanley
    Equal-Weight

    Institutional Ownership

    Screeners with CELUW included

    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    Biotech Companies
    Best performing stocks YTD
    • What is the ticker symbol for Celularity Inc.?
    • Does Celularity Inc. pay dividends?
    • What sector is Celularity Inc. in?
    • What industry is Celularity Inc. in?
    • What country is Celularity Inc. based in?
    • When did Celularity Inc. go public?
    • Is Celularity Inc. in the S&P 500?
    • Is Celularity Inc. in the NASDAQ 100?
    • Is Celularity Inc. in the Dow Jones?
    • When does Celularity Inc. report earnings?

    What is the ticker symbol for Celularity Inc.?

    The ticker symbol for Celularity Inc. is NASDAQ:CELUW

    Does Celularity Inc. pay dividends?

    No, Celularity Inc. does not pay dividends

    What sector is Celularity Inc. in?

    Celularity Inc. is in the Healthcare sector

    What industry is Celularity Inc. in?

    Celularity Inc. is in the Biotechnology industry

    What country is Celularity Inc. based in?

    Celularity Inc. is headquartered in United States

    When did Celularity Inc. go public?

    Celularity Inc.'s initial public offering (IPO) was on July 19, 2021

    Is Celularity Inc. in the S&P 500?

    No, Celularity Inc. is not included in the S&P 500 index

    Is Celularity Inc. in the NASDAQ 100?

    No, Celularity Inc. is not included in the NASDAQ 100 index

    Is Celularity Inc. in the Dow Jones?

    No, Celularity Inc. is not included in the Dow Jones index

    When does Celularity Inc. report earnings?

    The date for Celularity Inc.'s next earnings report has not been announced yet
    On this page